Padsevonil
Padsevonil (UCB 0942) is an orally administered small molecule compound, being developed by UCB Biopharma, for the treatment of drug refractory epilepsy and partial-onset seizures in patients with drug refractory epilepsy. Reference standards of Padsevonil API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Padsevonil
[catalogue_number] => PA 16 2790000
[category_ids] => ,78,75,70,76,82,
[chemical_name] =>
[weight] => 432.79
[form] => C14H14ClF5N4O2S
[cas] => 1294000-61-5
[pslug] => 1294000-61-5-padsevonil-api-pa162790000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 16 2790000
Molecular Formula : C14H14ClF5N4O2S
Molecular Weight : 432.79